Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 20 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Manika, Aikaterini [Clear All Filters]
Relationship of age and psychosocial factors with biological ratings in patients with end-stage renal disease undergoing dialysis.
Aging Clinical and Experimental Research. 14(5), 354 - 360.
(2002). Efficacy and Safety of Erythromycin as Sclerosing Agent in Patients With Recurrent Malignant Pleural Effusion.
American Journal of Clinical Oncology. 31(4), 384 - 389.
(2008).
(2014).
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
European Respiratory Journal. 49(5), 1700387.
(2017). Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis PatientsABSTRACT.
Antimicrobial Agents and Chemotherapy. 63(7),
(2019). Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit PatientsABSTRACT.
Antimicrobial Agents and Chemotherapy. 63(3),
(2019). A rare pulmonary pathology complicated with an unusual condition.
Breathe. 15(2), 121 - 127.
(2019). 18F-FDG PET/CT contribution to tuberculous vertebral osteomyelitis diagnosis: a case report..
Oxf Med Case Reports. 2020(9), omaa068.
(2020). Longitudinal Changes in Exercise Capacity among Adult Cystic Fibrosis Patients.
Advances in Respiratory Medicine. 88(5), 420 - 423.
(2020).
(2020). Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019..
Emerg Infect Dis. 27(7), 1997-1999.
(2021). Severe Pulmonary Disease Caused by Mycolicibacter kumamotonensis..
Emerg Infect Dis. 27(3), 962-964.
(2021). Adherence to inhaled therapies over 4 years in people with cystic fibrosis..
Pediatr Pulmonol. 57(4), 956-964.
(2022). BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis..
Sarcoidosis Vasc Diffuse Lung Dis. 38(4), e2021039.
(2022). Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study..
J Bras Pneumol. 48(2), e20220087.
(2022). Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity?.
Pediatr Pulmonol. 57(12), 3017-3026.
(2022). Availability and costs of medicines for the treatment of tuberculosis in Europe.
Clinical Microbiology and Infection. 29(1), 77 - 84.
(2023). Evaluation of Pain Scales and Outcome in Critically Ill Patients of a Greek ICU..
J Pain Palliat Care Pharmacother. 37(1), 34-43.
(2023). Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.
Antibiotics. 12(2), 307.
(2023). Use of cystic fibrosis inhaled medication before and after elexacaftor/tezacaftor/ivacaftor initiation.
Journal of Cystic Fibrosis.
(2023).